​The Medical Oncology and Hematology Service Line specialty research group is an integrative group of research-inclined physicians that assess new evidence to inform and improve clinical care. This research page is a resource to aid in organizing interested clinicians, connect those involved in data-driven inquiry, and plan next steps for data collection that can inform clinical practice change.

Physicians Involved in Research

Director of Hematology-Oncology Research: Dr. Raymond Liu

Ongoing and Completed Oncology Projects, All Funding Mechanisms

Changes in utilization, staging, and treatment after implementation of regionalized care for upper gastrointestinal cancer.
Robert Li, Lisa Herrinton. Oncology. RAU. Ongoing.

Evaluating outcomes and efficiency of consolidated multidisciplinary care for head and neck cancer.
Charles Meltzer, Lori Sakoda. Oncology. DSRP. Ongoing.

Evaluation of structured reporting of lung nodules detected on chest CT.
Tom Urbania, Lisa Herrinton. Oncology. RAU. Ongoing.

Genetic testing of women with hereditary breast and ovarian cancer syndrome.
Bethan Powell, Larry Kushi. Oncology. DSRP. Ongoing.

Implementation of a new 4R Sequence of Care plan patient tool for Breast and Lung Cancer Patients.
Raymond Liu, Nancy Gordon. Oncology. Other. Ongoing.

Rapid case ascertainment and review for bladder cancer.
Andrea Harzstark, Liyan Liu. Oncology. RAU. Ongoing.

The impact of the use of anticoagulants and antiplatelets on the risk of hospitalization and mortality in patients with COVID-19.
Ashok Pai, Julie Schmittdiel, Jenny Dusendang. Oncology. RAU. Ongoing.

Time Trends in Therapies and Outcomes for a Community-based Population of Adults with Acute Myeloid Leukemia, 2013-2017.
Lisa Law, Lisa Herrinton. Oncology. RAU. Ongoing.

Adherence to Oral Chemotherapy in Patients with Solid Tumors.
Laurel Habel. Oncology. CB. Completed.

All-Stage melanoma: rapid case ascertainment.
Tatjana Kolevska, Lisa Herrinton. Oncology. RAU. Completed.

Assessing Adherence to Follow-Up Care After Low-Dose Computed Tomography Screening for Lung Cancer.
Lori Sakoda . Oncology. CB. Completed.

Assessing Gaps in Recommended Follow-up Surveillance for Survivors of Early-Stage Colorectal Cancer.
Lesile Manace Brenman, Devon Check. Oncology. TAP. Completed.

Assessing practice patterns and potential quality gaps in primary nodule evaluation.
Archan Shah, Dinesh Kotek, Lori Sakoda. Oncology. DSRP. Completed.

Assessing Trends in Breast Cancer Incidence, Screening and Mortality among Men: A 10-Year Observational Study of a Rare Disease..
Elizabeth Shurell Linehan . Oncology. CB. Completed.

Cancer Wizard.
David Baer, Tracy Lieu. Oncology. RAU. Completed.

Efficient triaging of adnexal masses (3 phases).
Betty Suh-Burgmann, Lisa Herrinton. Oncology. RAU. Completed.

Epithelial ovarian cancer: rapid case ascertainment.
Chunnan Liu, Lisa Herrinton. Oncology. RAU. Completed.

Gastric cancer: rapid case ascertainment.
Yan Li, Lisa Herrinton. Oncology. RAU. Completed.

Hodgkin's lymphomas: rapid case ascertainment.
Antoine Sayegh, Lisa Herrinton. Oncology. RAU. Completed.

Identifying Predictors of Complete Pathologic Response to Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer.
Andrea Harzstark. Oncology. CB. Completed.

Mesothelioma: rapid case ascertainment.
Jennifer (Marie) Suga, Lisa Herrinton. Oncology. RAU. Completed.

Mobile health mindfulness in cancer palliative care.
Tatjana Kolevska, Yan Li, Ai Kubo. Oncology. DSRP. Completed.

Patient reported outcomes in pancreatic cancer.
Piyush Srivastava, Stephen Van Den Eeden. Oncology. DSRP. Completed.

PRognostic Information SysteM (PRISM): refinement and testing in actual practice.
David Baer,Tracy Lieu. Oncology. DSRP. Completed.

Regionalization of testicular cancer.
Andrea Harzstark, Lisa Herrinton. Oncology. DSRP. Completed.

Sarcoma: rapid case ascertainment.
Minggui Pan, Lisa Herrinton. Oncology. RAU. Completed.

T- and NK- cell lymphomas: rapid case ascertainment.
Lisa Law, Lisa Herrinton. Oncology. RAU. Completed.

Testicular cancer: rapid case ascertainment.
Andrea Harzstark, Lisa Herrinton. Oncology. RAU. Completed.


Absolute risks of cervical precancer among women who fulfil exiting guidelines based on HPV and cytology cotesting.
International journal of cancer. 3/12/2019.
Landy R, Schiffman M, Sasieni PD, Cheung LC, Katki HA, Rydzak G, Wentzensen N, Poitras NE, Lorey T, Kinney WK, Castle PE.

Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study.
Lung cancer (Amsterdam, Netherlands). 2019-02.
Gadgeel SM, Lukas RV, Goldschmidt J, Conkling P, Park K, Cortinovis D, de Marinis F, Rittmeyer A, Patel JD, von Pawel J, O'Hear C, Lai C, Hu S, Ballinger M, Sandler A, Gandhi M, Fehrenbacher L.

Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib.
Anti-cancer drugs. 2/12/2019.
Wang SXY, Zhang BM, Wakelee HA, Koontz MZ, Pan M, Diehn M, Kunder CA, Neal JW.

Derived mammographic masking measures based on simulated lesions predict the risk of interval cancer after controlling for known risk factors: a case-case analysis.
Medical physics. 1/29/2019.
Hinton B, Ma L, Mahmoudzadeh AP, Malkov S, Fan B, Greenwood H, Joe B, Lee V, Strand F, Kerlikowske K, Shepherd J.

Early-onset triple-negative breast cancer in multiracial/ethnic populations: Distinct trends of prevalence of truncation mutations.
Cancer medicine. 3/12/2019.
Liu Q, Yao S, Zhao H, Hu Q, Kwan ML, Roh JM, Ambrosone CB, Kushi LH, Liu S, Zhu Q.

How far will the Voyager® take us?.
CNS oncology. 2/15/2019.
Levin VA.

Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas.
Breast cancer research : BCR. 1/14/2019.
Hoffman J, Fejerman L, Hu D, Huntsman S, Li M, John EM, Torres-Mejia G, Kushi L, Ding YC, Weitzel J, Neuhausen SL, Lott P, COLUMBUS Consortium, Echeverry M, Carvajal-Carmona L, Burchard E, Eng C, Long J, Zheng W, Olopade O, Huo D, Haiman C, Ziv E.

Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath Tumors.
American journal of clinical oncology. 3/25/2019.
Shurell-Linehan E, DiPardo BJ, Elliott IA, Graham DS, Eckardt MA, Dry SM, Nelson SD, Singh AS, Kalbasi A, Federman N, Bernthal NM, Eilber FC.

Prediagnostic serum organochlorine insecticide concentrations and primary liver cancer: A case-control study nested within two prospective cohorts.
International journal of cancer. 1/30/2019.
Engel LS, Zabor EC, Satagopan J, Widell A, Rothman N, O'Brien TR, Zhang M, Van Den Eeden SK, Grimsrud TK.

Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial.
JAMA oncology. 2/14/2019.
Bruner DW, Pugh SL, Lee WR, Dignam JJ, Low D, Swanson GP, Shah AB, Malone S, Michalski JM, Dayes IS, Seaward SA, Nguyen PL, Hall WA, Pisansky TM, Chen Y, Sandler HM, Movsas B.

Real-World Experiences with Pazopanib in Patients with Advanced Soft Tissue and Bone Sarcoma in Northern California.
Medical sciences (Basel, Switzerland). 3/18/2019.
Seto T, Song MN, Trieu M, Yu J, Sidhu M, Liu CM, Sam D, Pan M.

Recovering from Cystectomy: Patient Perspectives.
Bladder cancer (Amsterdam, Netherlands). 1/31/2019.
McMullen CK, Kwan ML, Colwell JC, Munneke JR, Davis JV, Firemark A, Brooks N, Grant M, Gilbert SM, Altschuler A.

Reproductive Factors and Mammographic Density: Associations Among 24,840 Women and Comparison of Studies Using Digitized Film-Screen Mammography and Full-Field Digital Mammography.
American journal of epidemiology. 3/13/2019.
Alexeeff SE, Odo NU, McBride R, McGuire V, Achacoso N, Rothstein JH, Lipson JA, Liang RY, Acton L, Yaffe MJ, Whittemore AS, Rubin DL, Sieh W, Habel LA.

Stromal Tumor-infiltrating Lymphocytes in NRG Oncology/NSABP B-31 Adjuvant Trial for Early-stage HER2-positive Breast Cancer.
Journal of the National Cancer Institute. 3/19/2019.
Kim RS, Song N, Gavin PG, Salgado R, Bandos H, Kos Z, Floris G, Eynden GGVD, Badve S, Demaria S, Rastogi P, Fehrenbacher L, Mamounas EP, Swain SM, Lawrence Wickerham D, Costantino JP, Paik S, Wolmark N, Geyer CE, Lucas PC, Pogue-Geile KL.

Targeted genomic profiling of acral melanoma.
Journal of the National Cancer Institute. 1/18/2019.
Yeh I, Jorgenson E, Shen L, Xu M, North JP, Shain AH, Reuss D, Wu H, Robinson WA, Olshen A, von Deimling A, Kwok PY, Bastian BC, Asgari MM.

Telehealth in Oncology During the COVID-19 Outbreak: Bringing the House Call Back Virtually.
Journal of Oncology Practice. 2020 May 4.
Liu R, Sundaresan T, Reed ME, Trosman JR, Weldon CB, Kolevska T.

The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2, and IGFBP-3 in a pooled analysis of 16,024 men from 22 studies.
International journal of cancer. 3/15/2019.
Eleanor L. Watts Aurora Perez‐Cornago Paul N. Appleby Demetrius Albanes Eva Ardanaz Amanda Black H. Bas Bueno‐de‐Mesquita June M. Chan Chu Chen S.A. Paul Chubb Michael B. Cook Mélanie Deschasaux Jenny L. Donovan Dallas R. English Leon Flicker Neal D. Freedman Pilar Galan Graham G. Giles Edward L. Giovannucci Marc J. Gunter Laurel A. Habel Christel Häggström Christopher Haiman Freddie C. Hamdy Serge Hercberg Jeff M. Holly Jiaqi Huang Wen‐Yi Huang Mattias Johansson Rudolf Kaaks Tatsuhiko Kubo J. Athene Lane Tracy M. Layne Loic Le Marchand Richard M. Martin E. Jeffrey Metter Kazuya Mikami Roger L. Milne Howard A. Morris Lorelei A. Mucci David E. Neal Marian L. Neuhouser Steven E. Oliver Kim Overvad Kotaro Ozasa Valeria Pala Claire H. Pernar Michael Pollak Mari‐Anne Rowlands Catherine A. Schaefer Jeannette M. Schenk Pär Stattin Akiko Tamakoshi Elin Thysell Mathilde Touvier Antonia Trichopoulou Konstantinos K. Tsilidis Stephen K. Van Den Eeden Stephanie J. Weinstein Lynne Wilkens Bu B. Yeap Timothy J. Key Naomi E. Allen Ruth C. Travis.

The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer.
Cancer causes & control : CCC. 1/17/2019.
Kwan ML, Kushi LH, Danforth KN, Roh JM, Ergas IJ, Lee VS, Cannavale KL, Harrison TN, Contreras R, Loo RK, Aaronson DS, Quesenberry CP, Tritchler D, Ghai NR, Quinn VP, Ambrosone CB, Zhang Y, Tang L.

Trends in Radiation Practices for Female Ocular Oncologists in North America: A Collaborative Study of the International Society of Ocular Oncology.
Ocular oncology and pathology. 2019-01.
Shah SN, Kogachi K, Correa ZM, Schefler AC, Aronow ME, Callejo SA, Cebulla CM, Day-Ghafoori S, Francis JH, Lally S, McCannel TA, Paton KE, Phan IT, Pointdujour-Lim R, Ramasubramanian A, Rath P, Shields CL, Skalet AH, Wells JR, Jennelle RL, Berry JL.

KP Researchers and Physicians featured at 2020 ASCO Conference. Click here to read more!